Severe acute respiratory syndrome coronavirus 2 infections are associated with greater risk
of both arterial and venous thromboembolic events. Pathophysiology and Clinical …

Introduction Venous and arterial thromboses are frequently observed complications in
patients with severe novel coronavirus disease 2019 (COVID-19) infection who require …

Purpose Critically ill COVID-19 patients have an increased risk of developing pulmonary
embolism (PE). Diagnosis of PE by point-of-care ultrasound (POCUS) might reduce the …

Purpose Patients with auto-antibodies neutralizing type I interferons (anti-IFN auto-Abs) are
at risk of severe forms of coronavirus disease 19 (COVID-19). The chest computed …

Background Most symptoms of coronavirus 2019 (COVID-19) are mild; however, some
patients experience cardiovascular complications, including thromboembolic events and …

Familial hypercholesterolemia (FH) is a hereditary condition caused by mutations in the lipid
pathway. The goal in managing FH is to reduce circulating low‐density lipoprotein …

Background Sources of heterogeneity in venous thromboembolism (VTE) risk in COVID-19
are unclear and comparisons to other viruses are lacking. Objectives To describe VTE risk in …

Objective To report clinical outcomes of COVID-19 related acute aortic thrombosis (AAT).
Methods Consecutive COVID-19 patients presenting with AAT between April 2020 and …

Venous thromboembolism (VTE) recurrence rates are three times higher in patients with
chronic or no risk factors compared with those who have transient risk factors after stopping …

Patients with cancer are increasingly susceptible to Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2) infection including a higher risk of developing severe infection …